Poseida Therapeutics, Inc (PSTX) PT Lowered to $17 at Piper Sandler
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts PSTX Hot Sheet
Price: $9.50 --0%
Rating Summary:
2 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 11 | New: 9
Rating Summary:
2 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 11 | New: 9
Join SI Premium – FREE
Piper Sandler analyst Edward Tenthoff lowered the price target on Poseida Therapeutics, Inc (NASDAQ: PSTX) to $17.00 (from $30.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Ferrari NV (RACE:IM) (RACE) PT Lowered to EUR395 at BofA Securities
- Pop Mart - H (9992:HK) PT Lowered to HK$156 at CLSA
- Yaskawa Electric (6506:JP) (YASKY) PT Lowered to JPY6,200 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
